期刊文献+

丙型肝炎病毒感染促进53BP1蛋白通过泛素-蛋白酶体途径降解的研究

Hepatitis C virus infection promotes the ubiquitination and degradation of 53BP1
原文传递
导出
摘要 目的探讨丙型肝炎病毒(Hepatitis C virus,HCV)对53BP1表达的影响及机制。方法建立HCV体外感染Huh7细胞模型,采用Western blot检测HCV感染对53BP1总蛋白、胞浆和胞核蛋白表达的影响,qPCR检测53BP1的mRNA表达,采用免疫荧光(Immunofluorescence,IF)方法检测HCV感染对53BP1亚细胞定位的影响;采用免疫组织化学(immunohistochemistry,IHC)法定量检测HCV相关肝癌中53BP1蛋白的表达,并与癌旁组织及正常肝脏相比较;采用免疫共沉淀(Co-Immunoprecipitation,CO-IP)方法检测HCV对53BP1蛋白泛素化水平的影响。结果HCV感染导致Huh7细胞53BP1蛋白的相对表达水平为(0.41±0.03),明显低于对照组(1.00±0.08),差异有统计学意义(P<0.01);在HCV感染后,胞核53BP1蛋白相对表达水平为(0.35±0.03),明显低于对照组(1.00±0.09),差异有统计学意义(P<0.01);而胞浆53BP1相对表达水平为(1.20±0.18),对照组相对表达水平为(1.00±0.17),两者表达无显著改变(P>0.05);HCV感染可导致53BP1蛋白,尤其是胞核53BP1蛋白的表达下降。免疫荧光结果显示HCV感染导致53BP1从胞核到胞浆的亚细胞定位改变;免疫组化结果显示,与正常肝脏相比,53BP1在HCV相关HCC的癌组织(P<0.01)和癌旁组织(P<0.05)中显著降低。机制分析表明HCV感染促进53BP1的泛素-蛋白酶体途径降解。结论HCV感染可致Huh7细胞53BP1发生由细胞核到细胞质的定位改变,并促进其通过泛素-蛋白酶体途径降解。 Objective To investigate the effect of hepatitis C virus(HCV)infection on the expression of 53BP1 and its mechanism.Methods Total,cytoplasmic,and nuclear 53BP1 protein after HCV infection were detected by western blotting.The expression of 53BP1 in normal liver and HCV-related HCC tissues was quantified by immunohistochemistry.The subcellular localization of 53BP1 cells were detected by immunofluorescence staining and the ubiquitination level of 53BP1 was determined by Co-Immunoprecipitation.Results The relative expression level of 53BP1 protein in Huh7 cells caused by HCV infection was(0.41±0.03),significantly lower than that in the control group(1.00±0.08),the difference was statistically significant(P<0.01);After HCV infection,the relative expression level of nuclear 53BP1 protein was(0.35±0.03),significantly lower than that in the control group(1.00±0.09),the difference was statistically significant(P<0.01).The relative expression level of cytoplasmic 53BP1 was(1.20±0.18)and that of control group was(1.00±0.17);There was no significant change in the expression of both groups(P>0.05).HCV infection can decrease the expression of 53BP1 protein,especially in the nucleus.Immunofluorescence showed that HCV infection could lead to a striking re-localization of 53BP1 from nucleus to cytoplasm.Compared with the normal liver tissues,significantly lower levels of 53BP1 were found in the HCC tumor(P<0.01)and adjacent tissues(P<0.05).Mechanism analysis showed that HCV infection promoted the ubiquitination and degradation of 53BP1.Conclusion HCV infection shifts the localization of 53BP1 from nucleus to cytoplasm and promote its ubiquitination and degradation.
作者 周亚莉 何玉林 乔冠华 金科 覃培芳 黄海涛 闫建国 ZHOU Ya-li;HE Yu-lin;QIAO Guan-hua;JIN Ke;QIN Pei-fang;HUANG Hai-tao;YAN Jian-guo(Faculty of Basic Medical Sciences,Guilin Medical University,Guilin,Guangxi,541004,China)
出处 《中国病原生物学杂志》 CSCD 北大核心 2022年第8期869-872,879,共5页 Journal of Pathogen Biology
基金 广西科技基地和人才专项(桂科AD18281010) 国家自然科学基金地区基金项目(No.82160517) 广西高等学校千名中青年骨干教师培育计划项目(桂教师范[2019]81号)。
关键词 肝细胞癌 丙型肝炎病毒 53BP1 泛素-蛋白酶体降解 HCC HCV 53BP1 ubiquitin and degradation
  • 相关文献

参考文献1

二级参考文献14

  • 1Miriam J Alter.Epidemiology of hepatitis C virus infection[J].World Journal of Gastroenterology,2007,13(17):2436-2441. 被引量:72
  • 2European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
  • 3F. Poordad,D. Dieterich.Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents[J].Journal of Viral Hepatitis.2012(7)
  • 4A. Sidney Barritt,Michael W. Fried.Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus[J].Gastroenterology.2012(6)
  • 5Jens Bukh.Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease[J].Gastroenterology.2012(6)
  • 6Esperance A.K. Schaefer,Raymond T. Chung.Anti?Hepatitis C Virus Drugs in Development[J].Gastroenterology.2012(6)
  • 7Johannes Vermehren,Christoph Sarrazin.The role of resistance in HCV treatment[J].Best Practice & Research Clinical Gastroenterology.2012(4)
  • 8El Sayed, Nasr,Kandeel, Amr,Genedy, Mohamed,Esmat, Gamal,Doss, Wahid,El Sayed, Manal,Al Gasseer, Naeema,Eltantawy, Nasr,El Bushra, Hassan,Talaat, Maha,Harmanci, Hande,Fontanet, Arnaud,Bernier, Adeline,Tohme, Rania A,Averhoff, Francisco.Progress Toward Prevention and Control of Hepatitis C Virus Infection - Egypt, 2001-2012[J].EN.2012(29)
  • 9Stéphane Chevaliez,Christophe Rodriguez,Jean–Michel Pawlotsky.New Virologic Tools for Management of Chronic Hepatitis B and C[J].Gastroenterology.2012(6)
  • 10S. Mauss,F. Berger,M. Vogel,H. Pfeiffer-Vornkahl,U. Alshuth,J. Rockstroh,C. Niederau,D. Hüppe.Therapieergebnisse für die chronische Hepatitis C mit Genotyp-5- und -6-Infektion in Deutschland[J].Z Gastroenterol.2012(05)

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部